AstraZeneca antibody cocktail shows reduced risk of Covid infection
11th Oct 2021 07:02
(Sharecast News) - AstraZeneca said its antibody cocktail to combat Covid-19 had achieved a "statistically significant reduction" in the risk of developing the virus or death in a phase 3 trial.
Read moreAstraZeneca seeks emergency approval for Covid antibody drug
5th Oct 2021 07:55
(Sharecast News) - AstraZeneca is seeking approval for a new Covid-19 treatment intended to help people who respond poorly to vaccines, the Anglo-Swedish drugs firm said on Tuesday.
Read moreAstraZeneca breast cancer drug wins US breakthrough therapy designation
4th Oct 2021 07:28
(Sharecast News) - AstraZeneca said its breast cancer drug Enhertu had been granted breakthrough therapy designation (BTD) in the US.
Read moreAstraZeneca to buy Caelum in $500m deal
29th Sep 2021 07:39
(Sharecast News) - AstraZeneca said on Wednesday that its newly-acquired Alexion business will buy the remaining shares of drug maker Caelum Biosciences for up to $500m.
Read moreAstraZeneca lupus drug gets approval in Japan
28th Sep 2021 08:01
(Sharecast News) - AstraZeneca said on Tuesday that its Saphnelo (anifrolumab) drug has been approved in Japan for the treatment of adult patients with systemic lupus erythematosus (SLE).
Read moreAstraZeneca reports latest positive results for 'Lynparza'
24th Sep 2021 07:28
(Sharecast News) - AstraZeneca said on Friday that positive high-level results from the 'PROpel' phase 3 trial showed 'Lynparza', or olaparib, in combination with abiraterone, demonstrated a statistically significant and clinically meaningful improvement in radiographic progression-free survival (rPFS) versus standard-of-care abiraterone, as a first-line treatment for men with metastatic castration-resistant prostate cancer (mCRPC), with or without homologous recombination repair (HRR) gene mutations.
Read moreAstraZeneca planning new Dublin manufacturing facility
21st Sep 2021 07:41
(Sharecast News) - AstraZeneca said on Tuesday that it is planning on establishing a next-generation active pharmaceutical ingredient (API) manufacturing facility for small molecules near Dublin, Ireland to secure its global supply network.
Read moreAstraZeneca upbeat on 'groundbreaking' Enhertu results
20th Sep 2021 07:29
(Sharecast News) - AstraZeneca said on Monday that detailed positive results from the head-to-head 'DESTINY-Breast03' phase 3 trial showed that Enhertu, or trastuzumab deruxtecan, demonstrated superior progression-free survival compared to trastuzumab emtansine (T-DM1).
Read moreSunday newspaper round-up: Breast cancer, Food shortages, IAG
19th Sep 2021 14:30
(Sharecast News) - The trial of a new drug to treat an aggressive form of breast cancer has "shattered expectations" raising hopes of a "cure", according to its maker, AstraZeneca. The British pharmaceuticals company said three quarters of women in the trial of its new drug, Enhertu, had shown no progression in their disease after 12 months compared with just a third treated with a different medicine. - Sunday Times
Read moreAstraZeneca reports positive results from latest Imfinzi trial
9th Sep 2021 16:25
(Sharecast News) - AstraZeneca said on Thursday that positive results from the 'Poseidon' phase 3 trial showed 'Imfinzi', or durvalumab, and tremelimumab, when added to platinum-based chemotherapy, demonstrated a statistically-significant and clinically-meaningful improvement in overall survival and progression-free survival compared to chemotherapy alone in the first-line treatment of patients with stage four metastatic non-small cell lung cancer (NSCLC).
Read moreAstraZeneca asthma products perform well in phase 3 trials
9th Sep 2021 07:41
(Sharecast News) - AstraZeneca said on Thursday that positive high-level results from the 'MANDALA' and 'DENALI' phase 3 trials of PT027, or albuterol/budesonide, at both 180/160mcg and 180/80mcg doses, met all primary endpoints.
Read moreScientists to begin human trials of cancer vaccine using AstraZeneca technology
3rd Sep 2021 13:07
(Sharecast News) - Researchers in the UK and Germany will begin human trials for a therapeutic cancer vaccine "shortly" that uses the same technology as AstraZeneca's Covid-19 shot.
Read moreEU approves AstraZeneca blood disorder treatment for children
3rd Sep 2021 07:43
(Sharecast News) - AstraZeneca said its Ultomiris blood disorder treatment has been approved in the European Union for expanded use to include children and adolescents.
Read moreEMA says no urgent need yet for booster Covid-19 vaccine doses
2nd Sep 2021 17:43
(Sharecast News) - There is no urgent need to give healthy adults a third Covid-19 vaccine dose, Europe's health regulator said.
Read moreBerenberg raises target price on AstraZeneca
2nd Sep 2021 09:58
(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker AstraZeneca from 9,500.0p to 10,000.0p on Thursday following the firm's second-quarter earnings results.
Read more